February 8-9, 2016 The Waldorf Astoria New York
Post# of 47
Posted On: 01/23/2016 1:12:16 PM
February 8-9, 2016 The Waldorf Astoria New York
The 18th Annual BIO CEO & Investor Conference
Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a biopharmacetuical company that develops and commercializes precision immunodiagnostic agents and immunotherapeutics using its precision-targeted platform, Manocept™, to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Lymphoseek® (technetium Tc 99m tilmanocept) injection, Navidea’s first commercial product from the Manocept platform, was approved by the FDA in March 2013 and in Europe in November 2014. Navidea’s strategy is to deliver superior growth and shareholder return by bringing to market novel immune cell targeted products and advancing the Company’s pipeline through global partnering and commercialization efforts. For more information, please visit www.navidea.com.
View Less
30 minutes
Rick Gonzalez
https://www.bio.org/events/conferences/bio-ce...sentations
The 18th Annual BIO CEO & Investor Conference
Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a biopharmacetuical company that develops and commercializes precision immunodiagnostic agents and immunotherapeutics using its precision-targeted platform, Manocept™, to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Lymphoseek® (technetium Tc 99m tilmanocept) injection, Navidea’s first commercial product from the Manocept platform, was approved by the FDA in March 2013 and in Europe in November 2014. Navidea’s strategy is to deliver superior growth and shareholder return by bringing to market novel immune cell targeted products and advancing the Company’s pipeline through global partnering and commercialization efforts. For more information, please visit www.navidea.com.
View Less
30 minutes
Rick Gonzalez
https://www.bio.org/events/conferences/bio-ce...sentations
(0)
(0)Navidea Biopharmaceuticals Inc. (NAVB) Stock Research Links
Scroll down for more posts ▼